Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12811582rdf:typepubmed:Citationlld:pubmed
pubmed-article:12811582lifeskim:mentionsumls-concept:C0027651lld:lifeskim
pubmed-article:12811582lifeskim:mentionsumls-concept:C0034703lld:lifeskim
pubmed-article:12811582lifeskim:mentionsumls-concept:C0751690lld:lifeskim
pubmed-article:12811582lifeskim:mentionsumls-concept:C1510411lld:lifeskim
pubmed-article:12811582lifeskim:mentionsumls-concept:C0021467lld:lifeskim
pubmed-article:12811582lifeskim:mentionsumls-concept:C0031437lld:lifeskim
pubmed-article:12811582lifeskim:mentionsumls-concept:C0018270lld:lifeskim
pubmed-article:12811582lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:12811582lifeskim:mentionsumls-concept:C0205359lld:lifeskim
pubmed-article:12811582lifeskim:mentionsumls-concept:C0021469lld:lifeskim
pubmed-article:12811582lifeskim:mentionsumls-concept:C2246239lld:lifeskim
pubmed-article:12811582lifeskim:mentionsumls-concept:C0443211lld:lifeskim
pubmed-article:12811582lifeskim:mentionsumls-concept:C1553412lld:lifeskim
pubmed-article:12811582lifeskim:mentionsumls-concept:C1880022lld:lifeskim
pubmed-article:12811582lifeskim:mentionsumls-concept:C1548328lld:lifeskim
pubmed-article:12811582lifeskim:mentionsumls-concept:C2911684lld:lifeskim
pubmed-article:12811582lifeskim:mentionsumls-concept:C0185117lld:lifeskim
pubmed-article:12811582pubmed:issue3lld:pubmed
pubmed-article:12811582pubmed:dateCreated2003-8-11lld:pubmed
pubmed-article:12811582pubmed:abstractTextTransplantable tumor (KE) and clone cell (KE-F11) lines were established from a spontaneous malignant schwannoma found in an aged F344 rat. The primary tumor and KE tumors consisted of oval or spindle cells arranged in ill-defined bundles. Cultured KE-F11 cells exhibited polygonal or spindle configurations. Immunohistochemically, neoplastic cells in KE and KE-F11 reacted to vimentin, S-100 protein, neuron-specific enolase, myelin basic protein, and glial fibrillary acidic protein in varying degrees, indicating neurogenic features; occasional cells reacted to alpha-smooth muscle actin. Cells positive for lysosomal enzymes (acid phosphatase and non-specific esterase), and ED1 (rat macrophage specific) were observed in KE-F11, and electron microscopically, cells with many lysosomes were frequently present, indicating expression of macrophage-like phenotypes. Bioassay analysis revealed that KE-F11 cells produced high levels of nerve growth factor. DNA synthesis was inhibited by addition of transforming growth factor-beta1 (TGF-beta1), and Northern blot analysis revealed that expression of c-myc, a cell cycle-related immediate early gene, was depressed by TGF-beta1. Likely, TGF-beta1 is a factor capable of inhibiting cellular growth of Schwann cells. mRNA expression of the low-density lipoprotein receptor-related protein (LRP) was seen in KE-F11 cells by Northern blot analysis, and the level was decreased by lipopolysaccharide (LPS) treatment. LRP may be attributable to regulation of Schwann cell functions. KE-F11 cells seeded on laminin-coated dishes exhibited more extended cytoplasmic projections than on collagen type I-coated dishes. The present study provides evidence that biological properties of malignant schwannoma-derived cells might be affected by exogenous factors such as TGF-beta1, LPS and laminin. These tumor lines may be useful for studies on pathobiological characteristics of Schwann cells.lld:pubmed
pubmed-article:12811582pubmed:languageenglld:pubmed
pubmed-article:12811582pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12811582pubmed:citationSubsetIMlld:pubmed
pubmed-article:12811582pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12811582pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12811582pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12811582pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12811582pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12811582pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12811582pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12811582pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12811582pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12811582pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12811582pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12811582pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12811582pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12811582pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12811582pubmed:statusMEDLINElld:pubmed
pubmed-article:12811582pubmed:monthSeplld:pubmed
pubmed-article:12811582pubmed:issn0001-6322lld:pubmed
pubmed-article:12811582pubmed:authorpubmed-author:TsukamotoYYlld:pubmed
pubmed-article:12811582pubmed:authorpubmed-author:SakumaSSlld:pubmed
pubmed-article:12811582pubmed:authorpubmed-author:YasuiHHlld:pubmed
pubmed-article:12811582pubmed:authorpubmed-author:LaMarreJJlld:pubmed
pubmed-article:12811582pubmed:authorpubmed-author:YamateJJlld:pubmed
pubmed-article:12811582pubmed:authorpubmed-author:KuwamuraMMlld:pubmed
pubmed-article:12811582pubmed:authorpubmed-author:ALIXDDlld:pubmed
pubmed-article:12811582pubmed:authorpubmed-author:KumagaiDDlld:pubmed
pubmed-article:12811582pubmed:issnTypePrintlld:pubmed
pubmed-article:12811582pubmed:volume106lld:pubmed
pubmed-article:12811582pubmed:ownerNLMlld:pubmed
pubmed-article:12811582pubmed:authorsCompleteYlld:pubmed
pubmed-article:12811582pubmed:pagination221-33lld:pubmed
pubmed-article:12811582pubmed:dateRevised2007-11-9lld:pubmed
pubmed-article:12811582pubmed:meshHeadingpubmed-meshheading:12811582...lld:pubmed
pubmed-article:12811582pubmed:meshHeadingpubmed-meshheading:12811582...lld:pubmed
pubmed-article:12811582pubmed:meshHeadingpubmed-meshheading:12811582...lld:pubmed
pubmed-article:12811582pubmed:meshHeadingpubmed-meshheading:12811582...lld:pubmed
pubmed-article:12811582pubmed:meshHeadingpubmed-meshheading:12811582...lld:pubmed
pubmed-article:12811582pubmed:meshHeadingpubmed-meshheading:12811582...lld:pubmed
pubmed-article:12811582pubmed:meshHeadingpubmed-meshheading:12811582...lld:pubmed
pubmed-article:12811582pubmed:meshHeadingpubmed-meshheading:12811582...lld:pubmed
pubmed-article:12811582pubmed:meshHeadingpubmed-meshheading:12811582...lld:pubmed
pubmed-article:12811582pubmed:meshHeadingpubmed-meshheading:12811582...lld:pubmed
pubmed-article:12811582pubmed:meshHeadingpubmed-meshheading:12811582...lld:pubmed
pubmed-article:12811582pubmed:meshHeadingpubmed-meshheading:12811582...lld:pubmed
pubmed-article:12811582pubmed:meshHeadingpubmed-meshheading:12811582...lld:pubmed
pubmed-article:12811582pubmed:meshHeadingpubmed-meshheading:12811582...lld:pubmed
pubmed-article:12811582pubmed:meshHeadingpubmed-meshheading:12811582...lld:pubmed
pubmed-article:12811582pubmed:meshHeadingpubmed-meshheading:12811582...lld:pubmed
pubmed-article:12811582pubmed:meshHeadingpubmed-meshheading:12811582...lld:pubmed
pubmed-article:12811582pubmed:meshHeadingpubmed-meshheading:12811582...lld:pubmed
pubmed-article:12811582pubmed:meshHeadingpubmed-meshheading:12811582...lld:pubmed
pubmed-article:12811582pubmed:meshHeadingpubmed-meshheading:12811582...lld:pubmed
pubmed-article:12811582pubmed:meshHeadingpubmed-meshheading:12811582...lld:pubmed
pubmed-article:12811582pubmed:meshHeadingpubmed-meshheading:12811582...lld:pubmed
pubmed-article:12811582pubmed:meshHeadingpubmed-meshheading:12811582...lld:pubmed
pubmed-article:12811582pubmed:meshHeadingpubmed-meshheading:12811582...lld:pubmed
pubmed-article:12811582pubmed:meshHeadingpubmed-meshheading:12811582...lld:pubmed
pubmed-article:12811582pubmed:meshHeadingpubmed-meshheading:12811582...lld:pubmed
pubmed-article:12811582pubmed:meshHeadingpubmed-meshheading:12811582...lld:pubmed
pubmed-article:12811582pubmed:meshHeadingpubmed-meshheading:12811582...lld:pubmed
pubmed-article:12811582pubmed:meshHeadingpubmed-meshheading:12811582...lld:pubmed
pubmed-article:12811582pubmed:meshHeadingpubmed-meshheading:12811582...lld:pubmed
pubmed-article:12811582pubmed:meshHeadingpubmed-meshheading:12811582...lld:pubmed
pubmed-article:12811582pubmed:year2003lld:pubmed
pubmed-article:12811582pubmed:articleTitleCharacterization of newly established tumor lines from a spontaneous malignant schwannoma in F344 rats: nerve growth factor production, growth inhibition by transforming growth factor-beta1, and macrophage-like phenotype expression.lld:pubmed
pubmed-article:12811582pubmed:affiliationLaboratories of Veterinary Pathology and Anatomy, Graduate School of Agriculture and Biological Sciences, Osaka Prefecture University, Gakuencho 1-1, Sakai, 599-8531 Osaka, Japan. yamate@vet.osakafu-u.ac.jplld:pubmed
pubmed-article:12811582pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12811582pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:12811582pubmed:publicationTypeIn Vitrolld:pubmed
pubmed-article:12811582pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed